This inventor holds 34 USPTO granted patents and 11 published patent applications and 12 EPO patents, primarily in Probiotic Bifidobacteria. Top assignees: Alimentary Health Limited, The Procter Gamble Company, The Iams Company. Active years: 2007-2023.
Location History:
- County Cork, IE (2013 - 2014)
- Co. Cork, IE (2015)
- Rathcormac, IE (2017 - 2020)
- Cork, IE (2007 - 2023)
Company Filing History:
13 out of 14 
9 out of 17,173 
8 out of 110 
Years Active: 2007-2023
Areas of Expertise:
Title: Liam Diarmuid O'Mahony: Innovator in Respiratory Viral Infections
Introduction: Liam Diarmuid O'Mahony is a notable inventor based in County Cork, Ireland, recognized for his substantial contributions to biotechnology. Holding an impressive portfolio of 34 patents, O'Mahony has made significant strides in developing treatments that address respiratory viral infections.
Latest Patents: Among his latest innovations are two patents focused on Bifidobacterium longum, which has shown the ability to modulate immune responses to respiratory virus infections. His research details specific strains and cell wall fractions from these strains that can be used prophylactically or therapeutically to combat viral infections, including influenza, rhinovirus, and respiratory syncytial virus (RSV). Notably, an isolated strain, NCIMB 42020, is highlighted for its efficacy in treating viral infections and preventing secondary bacterial infections associated with respiratory illnesses.
Career Highlights: O'Mahony's career is marked by his tenure at multiple influential companies, including Alimentary Health Limited and The Procter & Gamble Company. His work in these firms has allowed him to spearhead innovative projects and collaborate with other experts in the field, further advancing his research in immune modulation and infection prevention.
Collaborations: Throughout his career, O'Mahony has collaborated with prominent colleagues, including Barry Kiely and Thomas William-Maxwell Boileau. These partnerships have played a crucial role in the development and success of his inventions, fostering an environment of collective expertise and innovation.
Conclusion: Liam Diarmuid O'Mahony exemplifies the spirit of innovation in biotechnological research, particularly in the field of respiratory infections. His extensive patent portfolio and collaboration with industry leaders underscore the impact his work has on public health, offering promising avenues for future therapeutic approaches.